Preferred Label : Peroxisome biogenesis disorder 1b;
Symbol : PBD1B;
CISMeF acronym : PBD1B;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Infantile phytanic acid storage disease; Peroxisome biogenesis disorder (neonatal adrenoleukodystrophy/infantile refsum disease); Peroxisome biogenesis disorder (nald/ird); Adrenoleukodystrophy, autosomal neonatal; Refsum disease, infantile;
Description : The peroxisome biogenesis disorders (PBDs) neonatal adrenoleukodystrophy (NALD) and
infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger
syndrome spectrum (ZSS). The milder presentations and longer life spans of NALD and
IRD result in a more varied initial presentation and natural history. There has been
survival of mildly affected patients into adulthood. The phenotypic boundaries between
children labeled with NALD or IRD is often blurred and it seems more appropriate to
consider these disorders a continuum of PBD. While many children present in the newborn
period, others may not come to attention until later. Most children have hypotonia,
but unlike Zellweger syndrome there is a degree of psychomotor development - achieving
head control, sitting unsupported, and even walking independently. Many communicate
and although language is rare, there have been children who have near normal language
for age. Craniofacial features are similar to but less pronounced than in Zellweger
syndrome. Seizures may be present. Renal cysts and bony stippling are seen routinely.
In some individuals a leukodystrophy develops, with degeneration of myelin, loss of
previously acquired skills, and development of spasticity. This may stabilize, or
progress and be fatal. The most common manifestation in this group of patients that
is less apparent in ZS is the development of sensorineural hearing loss and retinitis
pigmentosa (summary by Steinberg et al., 2006). While Zellweger syndrome usually results
in death in the first year of life, children with the NALD presentation may reach
their teens, and those with the IRD presentation may reach adulthood (summary by Waterham
and Ebberink, 2012). Individuals with mutations in the PEX1 gene have cells of complementation
group 1 (CG1, equivalent to CGE). For information on the history of PBD complementation
groups, see 214100. - Genetic Heterogeneity of Peroxisome Biogenesis Disorder;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the peroxisome biogenesis factor 1 gene (PEX1, 602136.0001);
Laboratory abnormalities : Increased very long chain fatty acids (VLCFAs); Varying degrees of catalase import into peroxisomes; Peroxisome biogenesis disorder complementation group E, CGE; Peroxisome biogenesis disorder complementation group 1, CG1;
Prefixed ID : #601539;
Origin ID : 601539;
UMLS CUI : C0282527;
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)